Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Pediatr Nephrol 2017 02 7;32(2):297-309. Epub 2016 Oct 7.

Department of Pediatric Nephrology (804), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Background: The role of complement in the atypical form of hemolytic uremic syndrome (aHUS) has been investigated extensively in recent years. As the HUS-associated bacteria Shiga-toxin-producing Escherichia coli (STEC) can evade the complement system, we hypothesized that complement dysregulation is also important in infection-induced HUS.

Methods: Serological profiles (C3, FH, FI, AP activity, C3d, C3bBbP, C3b/c, TCC, αFH) and genetic profiles (CFH, CFI, CD46, CFB, C3) of the alternative complement pathway were prospectively determined in the acute and convalescent phase of disease in children newly diagnosed with STEC-HUS or aHUS. Serological profiles were compared with those of 90 age-matched controls.

Results: Thirty-seven patients were studied (26 STEC-HUS, 11 aHUS). In 39 % of them, including 28 % of STEC-HUS patients, we identified a genetic and/or acquired complement abnormality. In all patient groups, the levels of investigated alternative pathway (AP) activation markers were elevated in the acute phase and normalized in remission. The levels were significantly higher in aHUS than in STEC-HUS patients.

Conclusions: In both infection-induced HUS and aHUS patients, complement is activated in the acute phase of the disease but not during remission. The C3d/C3 ratio displayed the best discrepancy between acute and convalescent phase and between STEC-HUS and aHUS and might therefore be used as a biomarker in disease diagnosis and monitoring. The presence of aberrations in the alternative complement pathway in STEC-HUS patients was remarkable, as well.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-016-3496-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203860PMC
February 2017
84 Reads
2.860 Impact Factor

Publication Analysis

Top Keywords

stec-hus ahus
12
hemolytic uremic
8
stec-hus patients
8
serological profiles
8
uremic syndrome
8
acute convalescent
8
complement pathway
8
alternative complement
8
phase disease
8
convalescent phase
8
acute phase
8
complement
8
ahus
6
stec-hus
6
prospectively determined
4
determined acute
4
acute
4
newly diagnosed
4
activated acute
4
complement activated
4

References

(Supplied by CrossRef)

N Besbas et al.
Kidney Int 2006

JN George et al.
N Engl J Med 2014

D Westra et al.
Neth J Med 2012

V Fremeaux-Bacchi et al.
J Med Genet 2004

J Caprioli et al.
Blood 2006

E Goicoechea de Jorge et al.
Proc Natl Acad Sci U S A 2007

V Fremeaux-Bacchi et al.
Blood 2008

D Westra et al.
Nephrol Dial Transplant 2010

E Volokhina et al.
Pediatr Nephrol 2012

A Richards et al.
Proc Natl Acad Sci U S A 2003

M Delvaeye et al.
N Engl J Med 2009

Similar Publications